Erratum: VEGF Genetic Polymorphisms May Contribute to the Risk of Diabetic Nephropathy in Patients with Diabetes Mellitus: A Meta-Analysis (The Scientific World Journal vol. 2014 DOI: 10.1155/2014/624573);VEGF genetic polymorphisms may contribute to the risk of diabetic nephropathy in patients with diabetes mellitus: A meta-analysis

Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Sun, Li ^a   Yuan, Quan ^a   Cao, Ning ^b   Guo, Wei ^c   Yao, Li ^a   Feng, Jiang Min ^a   Ma, Jian Fei ^a   Wang, Li Ning ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^c Fourth People's Hospital of Shenyang   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN A;

ASIAN; CASE CONTROL STUDY; CAUCASIAN; CINAHL; CNKI DATABASE; COCHRANE LIBRARY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; EARLY DIAGNOSIS; EMBASE; ETHNICITY; GENE; GENETIC RISK; HUMAN; MEDLINE; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; VASCULAR ENDOTHELIAL GROWTH FACTOR GENE; WEB OF SCIENCE; ALLELE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; META ANALYSIS; RISK;

ALLELES; DIABETIC NEPHROPATHIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84907257208     PISSN: 23566140     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2020/6482307     Document Type: Erratum

References (41)

1. Inoki K., Mori H., Wang J., Suzuki T., Hong S., Yoshida S., Blattner S. M., Ikenoue T., Rüegg M. A., Hall M. N., Kwiatkowski D. J., Rastaldi M. P., Huber T. B., Kretzler M., Holzman L. B., Wiggins R. C., Guan K., mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. Journal of Clinical Investigation 2011 121 6 2181 2196 10.1172/JCI44771 2-s2.0-79957927211
2. Sayyed S. G., Gaikwad A. B., Lichtnekert J., Kulkarni O., Eulberg D., Klussmann S., Tikoo K., Anders H., Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10. Nephrology Dialysis Transplantation 2010 25 6 1811 1817 10.1093/ndt/gfp730 2-s2.0-77952983571
3. Deshpande A. D., Harris-Hayes M., Schootman M., Epidemiology of diabetes and diabetes-related complications. Physical Therapy 2008 88 11 1254 1264 10.2522/ptj.20080020 2-s2.0-55849120862
4. Katon W., Lyles C. R., Parker M. M., Karter A. J., Huang E. S., Whitmer R. A., Association of depression with increased risk of dementia in patients with type 2 diabetes: the diabetes and aging study. Archives of General Psychiatry 2012 69 4 410 417 10.1001/archgenpsychiatry.2011.154 2-s2.0-84859456953
5. Sakaguchi Y., Shoji T., Hayashi T., Suzuki A., Shimizu M., Mitsumoto K., Kawabata H., Niihata K., Okada N., Isaka Y., Rakugi H., Tsubakihara Y., Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal disease. Diabetes Care 2012 35 7 1591 1597 10.2337/dc12-0226 2-s2.0-84862866376
6. Nelson P. J., Alpers C. E., Glomerular disease in 2011: new clues to environmental influences in glomerular disease. Nature Reviews Nephrology 2012 8 2 65 66 10.1038/nrneph.2011.214 2-s2.0-84856429906
7. Villeneuve L. M., Natarajan R., The role of epigenetics in the pathology of diabetic complications. American Journal of Physiology: Renal Physiology 2010 299 1 F14 F25 10.1152/ajprenal.00200.2010 2-s2.0-77953860649
8. Kanwar Y. S., Sun L., Xie P., Liu F., Chen S., A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annual Review of Pathology: Mechanisms of Disease 2011 6 395 423 10.1146/annurev.pathol.4.110807.092150 2-s2.0-79751477368
9. Bates D. O., Vascular endothelial growth factors and vascular permeability. Cardiovascular Research 2010 87 2 262 271 10.1093/cvr/cvq105 2-s2.0-77954333963
10. Sheikpranbabu S., Ravinarayanan H., Elayappan B., Jongsun P., Gurunathan S., Pigment epithelium-derived factor inhibits vascular endothelial growth factor-and interleukin-1beta-induced vascular permeability and angiogenesis in retinal endothelial cells. Vascular Pharmacology 2010 52 1-2 84 94 10.1016/j.vph.2009.12.002 2-s2.0-80052735317
11. Dowlati A., Gray R., Sandler A. B., Schiller J. H., Johnson D. H., Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab: an eastern cooperative oncology group study. Clinical Cancer Research 2008 14 5 1407 1412 10.1158/1078-0432.CCR-07-1154 2-s2.0-40949111793
12. Vincenti V., Cassano C., Rocchi M., Persico M. G., Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 1996 93 8 1493 1495 10.1161/01.CIR.93.8.1493 2-s2.0-0029868465
13. Doi K., Noiri E., Fujita T., Role of vascular endothelial growth factor in kidney disease. Current Vascular Pharmacology 2010 8 1 122 128 10.2174/157016110790226606 2-s2.0-77949512505
14. Miller J. W., Le Couter J., Strauss E. C., Ferrara N., Vascular endothelial growth factor a in intraocular vascular disease. Ophthalmology 2013 120 1 106 114 10.1016/j.ophtha.2012.07.038 2-s2.0-84872021668
15. Kaul K., Hodgkinson A., Tarr J. M., Kohner E. M., Chibber R., Is inflammation a common retinal-renal-nerve pathogenic link in diabetes? Current Diabetes Reviews 2010 6 5 294 303 10.2174/157339910793360851 2-s2.0-79551482327
16. Long J., Wang Y., Wang W., Chang B. H. J., Danesh F. R., Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. The Journal of Biological Chemistry 2010 285 30 23457 23465 10.1074/jbc.M110.136168 2-s2.0-77954941124
17. Mironidou-Tzouveleki M., Tsartsalis S., Tomos C., Vascular endothelial growth factor (VEGF) in the pathogenesis of diabetic nephropathy of type 1 diabetes mellitus. Current Drug Targets 2011 12 1 107 114 10.2174/138945011793591581 2-s2.0-78650920801
18. Bonnefond A., Saulnier P., Stathopoulou M. G., Grarup N., Ndiaye N. C., Roussel R., Nezhad M. A., Dechaume A., Lantieri O., Hercberg S., Lauritzen T., Balkau B., El-Sayed Moustafa J. S., Hansen T., Pedersen O., Froguel P., Charpentier G., Marre M., Hadjadj S., Visvikis-Siest S., What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications? PLoS ONE 2013 8 2 e55921 10.1371/journal.pone.0055921 2-s2.0-84873542025
19. Avogaro A., Albiero M., Menegazzo L., de Kreutzenberg S., Fadini G. P., Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care 2011 34 supplement 2 S285 S290 10.2337/dc11-s239 2-s2.0-79959788211
20. Brosius F. C. III, Khoury C. C., Buller C. L., Chen S., Abnormalities in signaling pathways in diabetic nephropathy. Expert Review of Endocrinology and Metabolism 2010 5 1 51 64 10.1586/eem.09.70 2-s2.0-77949831941
21. Tavakkoly-Bazzaz J., Amoli M. M., Pravica V., Chandrasecaran R., Boulton A. J. M., Larijani B., Hutchinson I. V., VEGF gene polymorphism association with diabetic neuropathy. Molecular Biology Reports 2010 37 7 3625 3630 10.1007/s11033-010-0013-6 2-s2.0-77956963446
22. McKnight A., Maxwell A. P., Patterson C. C., Brady H. R., Savage D. A., Association of VEGF-1499C → T polymorphism with diabetic nephropathy in type 1 diabetes mellitus. Journal of Diabetes and its Complications 2007 21 4 242 245 10.1016/j.jdiacomp.2006.05.005 2-s2.0-34347251552
23. Nikzamir A., Esteghamati A., Hammedian A. A., Mahmoudi T., The role of vascular endothelial growth factor +405 G/C polymorphism and albuminuria in patients with type 2 diabetes mellitus. Molecular Biology Reports 2012 39 2 881 886 10.1007/s11033-011-0812-4 2-s2.0-84860321146
24. Buraczynska M., Ksiazek P., Baranowicz-Gaszczyk I., Jozwiak L., Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients. Nephrology Dialysis Transplantation 2007 22 3 827 832 10.1093/ndt/gfl641 2-s2.0-33847661430
25. Xiao Q., Zhang Y., Zhang N., Yu C. H., Fu X. H., Correlation of vascular endothelial growth factor gene C2587A polymorphism to diabetic nephropathy in type 2 diabetes mellitus. Journal of Hunan Normal University (Medical Science) 2011 8 1 24 26
26. Zhang X. H., Guo Y., Chen L. H., C936T polymorphism in 3′-untranslated region of vascular endothelial growth factor gene is associated with diabetic nephropathy in type 2 diabetics. Chinese Journal of Endocrinology and Metabolism 2008 24 3 299 301
27. Stang A., Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology 2010 25 9 603 605 10.1007/s10654-010-9491-z 2-s2.0-77957661914
28. Zintzaras E., Ioannidis J. P. A., HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics 2005 21 18 3672 3673 10.1093/bioinformatics/bti536 2-s2.0-24644511654
29. Peters J. L., Sutton A. J., Jones D. R., Abrams K. R., Rushton L., Comparison of two methods to detect publication bias in meta-analysis. The Journal of the American Medical Association 2006 295 6 676 680 10.1001/jama.295.6.676 2-s2.0-32144440794
30. Guo B. Q., Cao Y. G., Zhang Q. J., Association of the vascular endothelial growth factor gene polymorphism to diabetic nephropathy in type 2 diabetes mellitus. Chinese Journal of Diabetes 2008 16 465 468
31. He H., Jin C. J., He X. J., Association of the vascular endothelial growth factor gene polymorphism to diabetic nephropathy in type 2 diabetes mellitus. Journal of Practical Diabetology 2007 3 25 27
32. Li R. F., Wang Y. N., Li Y., Correlation of vascular endothelial growth factor gene polymorphism to diabetic nephropathy in type 2 diabetic mellitus. Chinese Journal of Nephrology 2005 21 28 31
33. Xue F., Liu H. L., Wang Y. N., Relationship of the level and gene polymorphism of vascular endothelial growth factor with type 2 diabetic nephropathy. Chinese Journal of Nephrology 2007 23 813 814
34. Zhang D. D., Wang G. Y., Wang X. X., Association between polymorphism of C936T in vascular endothelial growth factor gene and type 2 diabetic nephropathy. Journal of Practical Medicine 2008 24 1904 1906
35. Shibuya M., Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. Journal of Biochemistry 2013 153 1 13 19 10.1093/jb/mvs136 2-s2.0-84871633270
36. Pavlisa G., Kusec V., Kolonic S. O., Markovic A. S., Jaksic B., Serum levels of VEGF and bFGF in hypoxic patients with exacerbated COPD. European Cytokine Network 2010 21 2 92 98 10.1684/ecn.2010.0193 2-s2.0-77953909546
37. Schlingemann R. O., Van Noorden C. J. F., Diekman M. J. M., Tiller A., Meijers J. C. M., Koolwijk P., Wiersinga W. M., VEGF levels in plasma in relation to platelet activation, glycemic control, and microvascular complications in type 1 diabetes. Diabetes Care 2013 36 6 1629 1634 10.2337/dc12-1951 2-s2.0-84878255619
38. Senger D. R., Vascular endothelial growth factor: much more than an angiogenesis factor. Molecular Biology of the Cell 2010 21 3 377 379 10.1091/mbc.E09-07-0591 2-s2.0-76049126765
39. Chen S., Ziyadeh F. N., Vascular endothelial growth factor and diabetic nephropathy. Current Diabetes Reports 2008 8 6 470 476 10.1007/s11892-008-0081-3 2-s2.0-63149094688
40. Nakagawa T., Kosugi T., Haneda M., Rivard C. J., Long D. A., Abnormal angiogenesis in diabetic nephropathy. Diabetes 2009 58 7 1471 1478 10.2337/db09-0119 2-s2.0-67650236579
41. Yang X., Deng Y., Gu H., Lim A., Altankhuyag A., Jia W., Ma K., Xu J., Zou Y., Snellingen T., Liu X., Wang N., Liu N., Polymorphisms in the vascular endothelial growth factor gene and the risk of diabetic retinopathy in Chinese patients with type 2 diabetes. Molecular Vision 2011 17 3088 3096 2-s2.0-83055170830